Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Aipharma Global Holdings, Anpac Bio-Medical Science, Appili, Atara, Beximco, Biocytogen, Biovaxys Technology, Cynata, Diaprost, Envigo RMS, Eyegene, Fujifilm, Genelux, GL Capital, GL Mountrose Investment Two, Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine, Hutchmed, Immutep, JCR, Jiangsu Recbio Technology, Moderna, Newsoara, Otsuka, Pierre Fabre, Race Oncology, Radiopharm Theranostics, Sanofi, Sanofi Bangladesh, Shenzhen Rhegen, Shionogi, Signalchem Lifesciences, Sihuan, Soligenix, Sumitomo Dainippon, Sunovion, Takeda, Therapeutic Solutions International, Tonix, Trilink, VBI Vaccines, Viiv Healthcare, Wuhan Rhecogen, Xuanzhu.